Evidence map›Paper›PMID 28013492›Full record

SynthesisPathology oncology research : POR2017

Meta-Analysis for the Therapeutic Effect of Neoadjuvant Therapy in Resectable Esophageal Cancer.

Yusen Zhu, Min Liu, Xiaojing Yun, Dongmei Wang, Yuhuan Bai, Guizhi Zhang, Bei Ji, Changchun Jing

Abstract readMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Pathology oncology research : POR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yusen ZhuDepartment of Gastroenterology, The Second People's Hospital of Liaocheng, Linqing, Shandong, 252600, China.
Min LiuDepartment of Emergency, The Second People's Hospital of Liaocheng, Linqing, Shandong, 252600, China. minliu01@126.com.
Xiaojing YunDepartment of Gastroenterology, The Second People's Hospital of Liaocheng, Linqing, Shandong, 252600, China.
Dongmei WangDepartment of Gastroenterology, The Second People's Hospital of Liaocheng, Linqing, Shandong, 252600, China.
Yuhuan BaiDepartment of Gastroenterology, The Second People's Hospital of Liaocheng, Linqing, Shandong, 252600, China.
Guizhi ZhangDepartment of Gastroenterology, The Second People's Hospital of Liaocheng, Linqing, Shandong, 252600, China.
Bei JiDepartment of Gastroenterology, The Second People's Hospital of Liaocheng, Linqing, Shandong, 252600, China.
Changchun JingDepartment of Gastroenterology, The Second People's Hospital of Liaocheng, Linqing, Shandong, 252600, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to review the therapeutic effects of neoadjuvant chemoradiotherapy (NCRT), chemotherapy (NCT), and radiotherapy (NRT) on patients with resectable Esophageal cancer (EsC) by comparison with surgery alone (SA). PubMed, EMBASE and Cochrane were searched for eligible studies published up to March 2015. Cochrane reviews were used for quality assessment. Eight primary outcomes were analyzed. Risk ratios (RRs)/ hazard ratios (HRs) and corresponding 95% confidence intervals (95% CIs) were calculated using the random- or fixed- effects model. Heterogeneity was assessed using the Chi-square-based Q statistic and the I

Indexed as

AdultAgedAged, 80 and overChemoradiotherapyChemotherapy, AdjuvantEsophageal NeoplasmsHumansMiddle AgedNeoadjuvant TherapyRadiotherapy, AdjuvantSurvival RateEsophageal cancerMeta-analysisNeoadjuvant chemoradiotherapyNeoadjuvant chemotherapyNeoadjuvant radiotherapy

Identifiers

PMID28013492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.